000			01601 a2200445 4500
005			20250514033231.0
264		0	_c20020625
008			200206s 0 0 eng d
022			_a0022-3050
024	7		_a10.1136/jnnp.72.6.708 _2doi
040			_aNLM _beng _cNLM
100	1		_aAarsland, D
245	0	0	_aDonepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. _h[electronic resource]
260			_bJournal of neurology, neurosurgery, and psychiatry _cJun 2002
300			_a708-12 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCholinesterase Inhibitors _xadministration & dosage
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aCross-Over Studies
650	0	4	_aDonepezil
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndans _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMental Status Schedule
650	0	4	_aMiddle Aged
650	0	4	_aParkinson Disease _xcomplications
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aLaake, K
700	1		_aLarsen, J P
700	1		_aJanvin, C
773	0		_tJournal of neurology, neurosurgery, and psychiatry _gvol. 72 _gno. 6 _gp. 708-12
856	4	0	_uhttps://doi.org/10.1136/jnnp.72.6.708 _zAvailable from publisher's website
999			_c11921299 _d11921299